Ng, GB
Chong Ng, Tyne And Wear GB
Patent application number | Description | Published |
---|---|---|
20110304272 | Method, operating device, and lighting system - The application relates to a circuit for operating a light-emitting means, having a half-bridge or full-bridge circuit for providing a supply voltage for the at least one light-emitting means, and a control circuit for the closed-loop control of the operation of the light-emitting means and/or fault identification. A measurement signal which represents the current through the bridge circuit and/or a measurement signal which represents the lamp current and a measurement signal which represents the voltage across the at least one light-emitting means are supplied to the control circuit at the same input. | 12-15-2011 |
G. André Ng, Leicester GB
Patent application number | Description | Published |
---|---|---|
20130245474 | METHOD AND APPARATUS FOR EVALUATING CARDIAC FUNCTION - The present invention relates to a method for assessing the electrical function of a heart, comprising the steps of:—(1) for each of a plurality of leads of an ECG, determining a value derived from the output of that lead and which corresponds to an action potential duration; (2) for each of the plurality of leads of the ECG, determining a value derived from the output of that lead and which corresponds to a diastolic interval; (3) for each of the plurality of leads of the ECG, determining a relationship between the determined values for action potential duration and for diastolic interval; (3) assessing the differences between the determined relationships for each of the plurality of leads. The invention further relates to apparatus and a computer program that may be used in the method. | 09-19-2013 |
G. André Ng, Leicester GB
Patent application number | Description | Published |
---|---|---|
20130245474 | METHOD AND APPARATUS FOR EVALUATING CARDIAC FUNCTION - The present invention relates to a method for assessing the electrical function of a heart, comprising the steps of:—(1) for each of a plurality of leads of an ECG, determining a value derived from the output of that lead and which corresponds to an action potential duration; (2) for each of the plurality of leads of the ECG, determining a value derived from the output of that lead and which corresponds to a diastolic interval; (3) for each of the plurality of leads of the ECG, determining a relationship between the determined values for action potential duration and for diastolic interval; (3) assessing the differences between the determined relationships for each of the plurality of leads. The invention further relates to apparatus and a computer program that may be used in the method. | 09-19-2013 |
Gary Ka Lai Ng, Cheshire GB
Patent application number | Description | Published |
---|---|---|
20080271733 | Methods of Providing Medicinal Metal Components Having Through Holes - A metal component, in particular a metal component of a medicinal device, such as a pharmaceutical aerosol delivery device, having a through hole extending along an axis from a first surface ( | 11-06-2008 |
Jack Hoy-Gig Ng, Edinburgh GB
Patent application number | Description | Published |
---|---|---|
20140305791 | ADDITIVE METALLISATION PROCESS - The invention provides a method of reducing metal ions ( | 10-16-2014 |
Jason W.p. Ng, Newgate Street GB
Patent application number | Description | Published |
---|---|---|
20120217313 | MONITORING MOVEMENT - A monitoring device ( | 08-30-2012 |
Jason W. P. Ng, Suffolk GB
Patent application number | Description | Published |
---|---|---|
20100325074 | REMOTE MONITORING THRESHOLDS - Apparatus for generating a threshold value indicative of a status change, comprising a trend projection engine for processing a plurality of sensed values in an order of value size to generate a corresponding predicted value for each of the plurality of sensed values, by reference to a value sequence trend of the plurality of sensed values, a comparator for comparing one or more of the plurality of sensed values against their corresponding predicted values to identify an abnormal sensed value which differs from its corresponding predicted value by a pre-specified amount, and a threshold generator for using the abnormal sensed value to identify the threshold value. | 12-23-2010 |
Leong Ng, Leicester GB
Patent application number | Description | Published |
---|---|---|
20090081714 | Assays - Methods and assays for monitoring the cardiac health of a subject are provided. The method involves the detection of a urotensin surrogate in a sample leading to a more accurate and reliable diagnosis of early or late stages of decompensated heart failure, heart failure, risk of a heart failur in a subject than the measurement of the cyclic peptide of urotensin alone. | 03-26-2009 |
Leong L. Ng, Leicester GB
Patent application number | Description | Published |
---|---|---|
20100028921 | RISK STRATIFICATION FOR ACUTE CORONARY SYNDROME BY MEANS OF FRAGMENTS/PARTIAL PEPTIDES OF PROVASOPRESSIN, ESPECIALLY COPEPTIN OR NEUROPHYSIN II - The invention relates to a method for risk stratification for acute coronary syndrome (ACS), in particular acute myocardial infarction (AMI) and angina pectoris (AP), wherein provasopressin (proAVP) or fragments and partial peptides thereof, in particular copeptin or neurophysin II, is determined by an in vitro diagnosis. | 02-04-2010 |
20100151504 | DIAGNOSIS AND RISK CLASSIFICATION OF ACUTE CORONARY SYNDROME BY MEANS OF CT-PROET-1 IN COMBINATION WITH NT-PROBNP - The invention relates to a method for diagnosis and/or risk classification for acute coronary syndrome (ACS), in particular for acute myocardial infarct (AMI) and angina pectoris (AP) and/or a post-myocardial infarct, wherein a determination of the C-terminal pro-endothelin (CT-proET-1) or fragments and partial peptides therefrom, is carried out in combination with NT-proBNP. | 06-17-2010 |
20130344513 | RISK STRATIFICATION FOR ACUTE CORONARY SYNDROME BY MEANS OF FRAGMENTS/PARTIAL PEPTIDES OF PROVASOPRESSIN, ESPECIALLY COPEPTIN OR NEUROPHYSIN II - The invention relates to a method for risk stratification for acute coronary syndrome (ACS), in particular acute myocardial infarction (AMI) and angina pectoris (AP), wherein provasopressin (proAVP) or fragments and partial peptides thereof, in particular copeptin or neurophysin II, is determined by an in vitro diagnosis. | 12-26-2013 |
Leong Loke Ng, Leicester GB
Patent application number | Description | Published |
---|---|---|
20080213746 | Methods of Diagnosis and Risk Stratification of Adverse Events in Post Myocardial Infarction Patients Using Pro-adrenomedullin - The invention provides methods for the diagnosis and risk stratification of adverse events in post-myocardial infarction patients by means of proADM, whereby a determination of the marker pro-adrenomedullin or partial sequence or a fragment thereof or contained in a marker combination (panel, cluster) is carried out on a post-myocardial infarction patient. The invention also provides a diagnostic device and a kit for the performance of the method of the method of the invention. | 09-04-2008 |
20120142120 | VASOACTIVE HORMONE-BASED STRATIFICATION OF PATIENTS SUFFERING FROM DISEASES RELATED TO ENDOTHELIAL FUNCTION/DYSFUNCTION - The present invention relates to a method for the stratification of a subject having an acute or a chronic disease, wherein said disease effects endothelial function/dysfunction, comprising the steps of (i) taking a sample of bodily fluid from said subject; (ii) determining in said sample of bodily fluid the concentration of a vasoactive hormone or fragments thereof or precursors or fragments thereof having a length of at least 12 amino acid residues; (iii) stratifying said subjects into either of the categories: (a) responder to a medication for treatment of said disease, (b) non-responder to a medication for treatment of said disease not showing an unfavourable effect after having received said medication; (c) subjects showing an unfavourable effect after having received said medication. The invention also relates to the use of an antibody or a functional fragment thereof in the method according to the invention. | 06-07-2012 |
Leong Loke Ng, Leicestershire GB
Patent application number | Description | Published |
---|---|---|
20110117589 | USE OF PROCALCITONIN (PCT) IN PROGNOSIS FOLLOWING ACUTE CORONARY SYNDROMES - Subject of the present invention are assays and in vitro methods for determining a prognosis for a patient having an acute coronary syndrome, whereby the level of procalcitonin or fragments thereof is measured in a sample obtained from said patient. Said level of procalcitonin or fragments thereof may then be correlated to a predisposition to an adverse outcome of said acute coronary syndrome. | 05-19-2011 |
20110229911 | AZUROPHILIC GRANULE PROTEASES AS MARKERS IN CARDIOLOGICAL DISEASES - The present invention is concerned with an assay for detecting and/or determining the level of a protease from azurophilic granules of polymorphonuclear neutrophils or a complex thereof with an endogenous inhibitor for risk stratification and/or prognosis and/or therapy control and/or monitoring of a patient having a cardiological disease or condition. | 09-22-2011 |
Shieling Ng, Belfast GB
Patent application number | Description | Published |
---|---|---|
20130058852 | REMOVAL OF CARBON DIOXIDE FROM A GAS STREAM BY USING AQUEOUS IONIC LIQUID - The present invention relates to the separation of gases, and more specifically to an inventive process for the removal of carbon dioxide gas using carefully selected ionic liquid absorbents together with water in a carefully selected ratio. | 03-07-2013 |
Tony Tsz-Cheong Ng, London GB
Patent application number | Description | Published |
---|---|---|
20150104442 | PHOSPHOCOFILIN: COFILIN CO-LOCALIZATION INTENSITY AS A PREDICTOR OF METASTATIC RECURRENCE - Methods and products are provided for determining if a subject having a tumor is at risk of metastasis of the tumor. Specifically, the methods comprise detecting phosphorylated cofilin, and both phosphorylated and non-phosphorylated cofilin; quantifying the phosphorylated cofilin, and the total of phosphorylated and nonphosphorylated cofilin; and determining if a subject having the tumor is likely to experience metastasis of the tumor, based on the ratio of the amount of detected phosphorylated cofilin: total amount of phosphorylated and non-phosphorylated cofilin detected. Further disclosed are the types of tumor metastases that can be determined using the methods provided. | 04-16-2015 |
Yin Shan Eric Ng, London GB
Patent application number | Description | Published |
---|---|---|
20140335083 | METHODS OF TREATMENT AND PREVENTION OF EYE DISEASES - The present invention provides compositions and methods useful for treating and preventing neovascular AMD by inhibition of CCR3. The compositions and methods are useful for treating and preventing diseases and disorders such as but not limited to, neovascular AMD | 11-13-2014 |